S&P 500 Futures
(0.18%) 5 336.75 points

Dow Jones Futures
(0.06%) 40 161 points

Nasdaq Futures
(0.28%) 18 687 points

Oil
(-0.47%) $79.68

Gas
(1.52%) $2.67

Gold
(0.62%) $2 432.40

Silver
(1.30%) $31.67

Platinum
(-0.90%) $1 080.20

USD/EUR
(0.09%) $0.921

USD/NOK
(0.04%) $10.68

USD/GBP
(0.05%) $0.787

USD/RUB
(-0.43%) $90.58

Realtime updates for Equillium Inc [EQ]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Upcoming Earnings Alert

2 days till quarter result
(tns 2024-05-22)

Expected move: +/- 10.46%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

1.30% $ 1.560

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need...

Stats
Today's Volume	31 380.00
Average Volume	188 385
Market Cap	55.00M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.0900 ) 2024-05-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.46
ATR14	$0.0170 (1.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Tom Penny	Sell	0	Common Stock
2024-03-06	Tom Penny	Sell	45 000	Employee Stock Option (right to buy)
2024-03-06	Tom Penny	Sell	40 000	Employee Stock Option (right to buy)
2024-03-06	Tom Penny	Sell	60 000	Employee Stock Option (right to buy)
2024-03-06	Tom Penny	Sell	40 000	Employee Stock Option (right to buy)

INSIDER POWER
61.13
Last 97 transactions
Buy: 3 858 069 \| Sell: 577 250

Volume Correlation

Long: 0.03 (neutral)

Short: -0.58 (weak negative)

Signal:(51.785) Neutral

Equillium Inc Correlation

10 Most Positive Correlations
PXLW	0.932
COHR	0.91
CFLT	0.905
PEPG	0.898
ULCC	0.893
KTCC	0.893
CYBR	0.888
KYMR	0.887
SLN	0.886
ADAP	0.883

10 Most Negative Correlations
DSWL	-0.883
HIFS	-0.856
BSGM	-0.855
DCOM	-0.845
FINW	-0.844
BLKB	-0.838
OSBC	-0.834
MYFW	-0.83
OMCL	-0.828
GSM	-0.827

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Equillium Inc Correlation - Currency/Commodity

0.25
( neutral )

0.25
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.42
( neutral )

Equillium Inc Financials

Annual	2023
Revenue:	$36.08M
Gross Profit:	$35.96M (99.65 %)
EPS:	$-0.380

FY	2023
Revenue:	$36.08M
Gross Profit:	$35.96M (99.65 %)
EPS:	$-0.380

FY	2022
Revenue:	$15.76M
Gross Profit:	$15.64M (99.25 %)
EPS:	$-3.19

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.579

Financial Reports:

No articles found.

Equillium Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.